Macro Tsimmis

intelligently hedged investment

Neurocrine Biosciences (NBIX) update #2

Posted by intelledgement on Tue, 21 Aug 07

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the FDA have accepted the company’s resubmission of its NDA for 5 mg and 10 mg capsules of the prospective insomnia drug indiplon and that the FDA has set a PDUFA action date of 12 December 2007.

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

 
%d bloggers like this: